Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complication in Systemic Lupus Erythematosus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT00404157
What this trial is testing

Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970g

Who this might be right for
Lupus Nephritis
Genentech, Inc.
Large-scale testing (Phase 3)Study completedNCT00615173
What this trial is testing

Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

Who this might be right for
Kidney DiseasesLupus NephritisTacrolimus+2 more
Sun Yat-sen University 81
Large-scale testing (Phase 3)Study completedNCT00377637
What this trial is testing

Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Hoffmann-La Roche 370
Post-approval studies (Phase 4)Looking for participantsNCT07323524
What this trial is testing

Dapagliflozin in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Brigham and Women's Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT01930890
What this trial is testing

BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Biogen 87
Not applicableLooking for participantsNCT04449991
What this trial is testing

Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Karolinska Institutet 206
Testing effectiveness (Phase 2)Looking for participantsNCT06557265
What this trial is testing

NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Who this might be right for
Lupus NephritisPrimary Membranous Nephropathy
Nkarta, Inc. 120
Testing effectiveness (Phase 2)Looking for participantsNCT06058078
What this trial is testing

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Jiangsu Renocell Biotech Company 60
Not applicableUnknownNCT05451277
What this trial is testing

At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring

Who this might be right for
Systemic Lupus ErythematosusPlacenta-mediated Pregnancy ComplicationsHydroxychloroquine+5 more
Evelyne Vinet 120
Not applicableUnknownNCT03958851
What this trial is testing

Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 120
Not applicableWithdrawnNCT00908986
What this trial is testing

Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis

Who this might be right for
Lupus Nephritis
Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Not applicableUnknownNCT06491602
What this trial is testing

Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital

Who this might be right for
Lupus Nephritis
Sohag University 30
Testing effectiveness (Phase 2)Study completedNCT04643470
What this trial is testing

Zanubrutinib in Participants With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
BeiGene 177
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07393451
What this trial is testing

Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Simcere Pharmaceutical Co., Ltd 60
Not applicableUnknownNCT05120882
What this trial is testing

Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University Hospital

Who this might be right for
Lupus Nephritis
Assiut University 60
Testing effectiveness (Phase 2)Study completedNCT02949973
What this trial is testing

Aurinia Early Urinary Protein Reduction Predicts Response

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 10
Large-scale testing (Phase 3)Ended earlyNCT00626197
What this trial is testing

Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Genentech, Inc. 381
Testing effectiveness (Phase 2)Looking for participantsNCT07523542
What this trial is testing

SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus

Who this might be right for
REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSLupus Nephritis
Beijing Biotech 24
Next Page